Provided by Tiger Fintech (Singapore) Pte. Ltd.

Acasti Pharma

3.37
+0.0000
Volume:- -
Turnover:92.82K
Market Cap:34.17M
PE:-3.06
High:3.37
Open:3.37
Low:3.37
Close:3.37
Loading ...

Company Profile

Company Name:
Acasti Pharma
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Acasti Pharma Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. The company's lead product candidate is the GTX-104, an intravenous infusion to treat subarachnoid hemorrhage. It also develops GTX-102, an oral mucosal spray for the treatment of ataxia-telangiectasia; and GTX-101, a topical bioadhesive film-forming bupivacaine spray for postherpetic neuralgia. The company was incorporated in 2002 and is headquartered in Laval, Canada.